Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Steven Tzewei Chen, M.D.

Co-Author

This page shows the publications co-authored by Steven Chen and Amy Blum.
Connection Strength

1.149
  1. Association between common medication triggers and severity of cutaneous immune-related adverse events. J Am Acad Dermatol. 2021 Apr 18.
    View in: PubMed
    Score: 0.233
  2. Prognostic significance of cutaneous immune-related adverse events in patients with melanoma and other cancers on immune checkpoint inhibitors. J Am Acad Dermatol. 2022 04; 86(4):886-889.
    View in: PubMed
    Score: 0.232
  3. Patterns and prognostic significance of cutaneous immune-related adverse events in non-small cell lung cancer. Eur J Cancer. 2021 04; 147:13-16.
    View in: PubMed
    Score: 0.230
  4. Cutaneous toxicities of immune checkpoint inhibitors in patients with altered immunity. J Am Acad Dermatol. 2022 01; 86(1):172-174.
    View in: PubMed
    Score: 0.229
  5. Impact of ethnicity on the diagnosis and management of cutaneous toxicities from immune checkpoint inhibitors. J Am Acad Dermatol. 2021 Mar; 84(3):851-854.
    View in: PubMed
    Score: 0.225
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.